Emil von Behring

CSL Behring is a global biopharmaceutical leader specializing in the development and manufacture of plasma-derived and recombinant therapeutic products. The company traces its origins to the Behringwerke founded by Nobel laureate Emil von Behring in 1904. Today, it provides life-saving medicines for rare and serious diseases, including bleeding disorders, immune deficiencies, and respiratory conditions. CSL Behring is a subsidiary of CSL Limited and operates one of the world's largest plasma collection networks. The company is headquartered in King of Prussia, Pennsylvania, with major operations in Marburg, Germany, and Bern, Switzerland.